top of page
cdc-IFpQtennlj8-unsplash.jpg

EOAR SEMINAR, JUNE 2024

The limits of regulatory pharmaceuticalisation? Global developments supporting clinical innovation with advanced therapies

Dr Michael Morrison (University of Oxford)

On the 11th of June 2024, EOAR hosted Dr Michael Morrison from the University of Oxford. In his presentation, Michael made the case for clinically-led innovation around cell therapies. Michael also discussed two alternatives to standard stem cell product development, namely the European Union hospital exemption in Spain and the Act on the Safety of Regenerative Medicine in Japan.

bottom of page